Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL160940 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL160941 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL29406424 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL3714514 | 0.89 | ALDH1A1 (0.54) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL2857543 | 0.85 | ALDH1A1 (0.60) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL2857545 | 0.85 | ALDH1A1 (0.60) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| Phenylethyl Alcohol SCHEMBL9017468 | 0.84 | ALDH1A1 (0.44) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL22245027 | 0.84 | ALDH1A1 (0.52) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL244549 | 0.83 | ALDH1A1 (0.54) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL17923373 | 0.82 | ALDH1A1 (0.60) | ALDH1A1CYP3A4ALOX15TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 394 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024213536-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| EP-4262735-A1 | TREATMENT COMPOSITIONS COMPRISING PLANT ROSIN MATERIALS | The Procter & Gamble Company (US) | 2023-10-25 | — | — | EP | claimed |
| CN-116917450-A | Treatment composition comprising plant rosin material | 宝洁公司 | 2023-10-20 | — | — | CN | claimed |
| EP-3416729-B1 | PRO-FRAGRANCE COMPOSITION | AQDOT LTD (GB) | 2023-09-20 | — | — | EP | claimed |
| WO-2022133426-A1 | TREATMENT COMPOSITIONS COMPRISING PLANT ROSIN MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2022-06-23 | — | — | WO | claimed |
| US-20220195348-A1 | TREATMENT COMPOSITIONS COMPRISING PLANT ROSIN MATERIAL AND CERTAIN PERFUME RAW MATERIALS | THE PROCTER & GAMBLE COMPANY | 2022-06-23 | — | — | US | claimed |
| CN-108601958-B | Pro-fragrance compositions | 爱客多有限公司 | 2022-06-17 | — | — | CN | claimed |
| US-11326126-B2 | High performing, high impact bloom accord | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2022-05-10 | — | — | US | claimed |
| US-11002716-B2 | Method of resolving defined known or suspected allergens in a complex mixture of perfume ingredients, and compositions | GIVAUDAN SA (CH) | 2021-05-11 | — | — | US | claimed |
| EP-2969027-B1 | COMPOSITIONS OF ALKYLAMIDOTHIAZOLES AND FRAGRANCES | BEIERSDORF AG (DE) | 2020-10-14 | — | — | EP | claimed |
| EP-2969027-A1 | COMPOSITIONS CONSISTING OF ALKYLAMIDOTHIAZOLES AND AROMATIC SUBSTANCES | Beiersdorf AG (DE) | 2016-01-20 | — | — | EP | claimed |
| CN-105007991-A | Combinations of alkylamidothiazoles and aromatic substances | BEIERSDORF AG | 2015-10-28 | — | — | CN | claimed |
| CN-104955934-A | Treatment compositions comprising microcapsules, primary or secondary amines, and formaldehyde scavengers | PROCTER & GAMBLE | 2015-09-30 | — | — | CN | claimed |
| WO-2014139758-A1 | COMPOSITIONS CONSISTING OF ALKYLAMIDOTHIAZOLES AND AROMATIC SUBSTANCES | BEIERSDORF AG (DE) | 2014-09-18 | — | — | WO | claimed |
| WO-2014116469-A1 | TREATMENT COMPOSITIONS COMPRISING MICROCAPSULES, PRIMARY OR SECONDARY AMINES, AND FORMALDEHYDE SCAVENGERS | THE PROCTER & GAMBLE COMPANY (US) | 2014-07-31 | — | — | WO | claimed |
| US-20140201927-A1 | TREATMENT COMPOSITIONS COMPRISING MICROCAPSULES, PRIMARY OR SECONDARY AMINES, and FORMALDEHYDE SCAVENGERS | THE PROCTER & GAMBLE COMPANY (US) | 2014-07-24 | — | — | US | claimed |
| EP-2757146-A1 | Treatment compositions comprising microcapsules, primary or secondary amines, and formaldehyde scavengers | The Procter & Gamble Company (US) | 2014-07-23 | — | — | EP | claimed |
| CN-101790367-B | Cosmetic emulsifier composition | BEIERSDORF AG | 2013-01-23 | — | — | CN | claimed |
| US-20100247476-A1 | Copolymer Containing Water-Soluble Lipids | Societe d'Exploitation de Products Pour Les Industries Chimiques SEPPIC (FR) | 2010-09-30 | — | — | US | claimed |
| CN-101790367-A | Cosmetic emulsifier composition | BEIERSDORF AG | 2010-07-28 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100247476-A1 | Copolymer Containing Water-Soluble Lipids | LIPA, PHOSPHO1, ABHD16A | ALDH1A1 1643/4885CYP3A4 3371/4885ALOX15 319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.